[Successful chronic treatment with sildenafil in a patient with end-stage heart failure following Fontan procedure]

Related Experiment Video

Updated: Jun 3, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Jacek Białkowski1, Jarosław Rycaj, Roland Fiszer

  • 1Oddział Kliniczny Wrodzonych Wad Serca i Kardiologii Dziecięcej, Śląski Uniwersytet Medyczny, Śląskie Centrum Chorób Serca, Zabrze. abi_med@poczta.onet.pl

Kardiologia Polska
|March 25, 2011
PubMed

Insights

Sildenafil effectively treated severe heart failure in a Fontan patient with high pulmonary vascular resistance. This long-term medication improved symptoms of heart insufficiency, offering a new therapeutic option.

Area of Science:

  • Cardiology
  • Pulmonary Hypertension
  • Pediatric Cardiac Surgery

Background:

  • The Fontan procedure is a palliative surgery for complex congenital heart defects.
  • Increased pulmonary vascular resistance (PVR) and pulmonary artery pressure (PAP) are significant long-term complications after Fontan surgery.
  • Severe heart insufficiency can develop due to elevated PVR and PAP in Fontan patients.

Observation:

  • A 21-year-old male, 17 years post-Fontan correction, presented with severe heart insufficiency (NYHA class III).
  • The patient exhibited cachexia, massive peripheral edema, and ascites.
  • These symptoms were attributed to significantly increased pulmonary vascular resistance and pulmonary artery pressure.

Findings:

  • Long-term sildenafil medication was administered to the patient.
  • Sildenafil treatment resulted in successful management of the severe heart insufficiency symptoms.
  • The patient showed significant clinical improvement following sustained sildenafil therapy.

Implications:

  • Sildenafil may be a viable long-term treatment option for Fontan patients with heart failure secondary to increased PVR and PAP.
  • This case highlights the potential of targeted pharmacotherapy to manage late complications of Fontan circulation.
  • Further research is warranted to explore the efficacy and safety of sildenafil in similar patient populations.

More Related Videos

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...